CT0180

ⁱ

Other names: CT0180, GPC3 CAR-T, glypican-3 (GPC3) directed CAR-T cell therapy, CSG-GPC3, Glypican 3 chimeric antigen receptor T cell therapy, KJgpc3-001, CAR-GPC3 T Cells, chimeric antigen receptor T cells targeting glypican-3, GPC3-CAR/CSG-GPC3, GPC3-CAR-T cell therapy, anti-GPC3 CAR T

News alerts, weekly reports and conference planners

Associations

News

Trials

Company:

CARsgen

Drug class:

GPC-3-targeted CAR-T immunotherapy

Related drugs:

‹

CT017 (1)

ADI-002 (0)